Jean Lopategui, MD

Jean Lopategui, MD, discusses the evolution of targeted therapies in non–small cell lung cancer.

Jean Lopategui, MD, discusses the evolution of molecular testing in non–small cell lung cancer.

Jean Lopategui, MD, associate professor of pathology and director of Translational Genomics and of the Molecular Genetics Pathology Fellowship at Cedars-Sinai, discusses the implications of genomic sequencing in lung cancer.

Jean Lopategui, MD, discusses the use of liquid biopsies in lung cancer.